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BACKGROUND: Relative survival after cancer in Finland is at the highest level observed in Europe and has, in general, been on a steady
increase. The aim of this study is to assess whether the high survival is equally shared by different population subgroups and to
estimate the possible gains that might be achieved if equity prevailed.
MATERIALS AND METHODS: The educational level and occupation before the cancer diagnosis of patients diagnosed in Finland in
1971–2005 was derived from an antecedent population census. The cancers were divided into 27 site categories. Cancer (cause)-
specific 5-year survival proportions were calculated for three patient categories based on the educational level and for an
occupational group of potentially health-conscious patients (physicians, nurses, teachers etc.). Proportions of avoidable deaths were
derived by assuming that the patients from the two lower education categories would have the same mortality owing to cancer,
as those from the highest educational category. Estimates were also made by additionally assuming that even the mortalities owing
to other causes of death were all equal to those in the highest category.
RESULTS: For almost all the sites considered, survival was consistently highest for patients with the highest education and lowest for
those with only basic education. The potentially health-conscious patients had an even higher survival. The differences were, in part,
attributable to less favourable distributions of tumour stages in the lower education categories. In 1996–2005, 4–7% of the deaths in
Finnish cancer patients could have potentially been avoided during the first 5-year period after diagnosis, if all the patients had the
same cancer mortality as the patients with the highest educational background. The proportion would have also been much higher,
8–11%, if, in addition, the mortality from other causes had been the same as that in the highest educational category.
INTERPRETATION: Even in a potentially equitable society with high health care standards, marked inequalities persist in cancer survival.
Earlier cancer diagnosis and the ability to cope within the health care system may be a partly relevant explanation, but personal habits
and lifestyles also have a role, particularly for the cancer patients’ mortality from other causes of death than cancer.
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Finland has one of the highest relative survival for cancer patients
in Europe (Capocaccia et al, 2009). Studies in Denmark and the
UK, countries with lower relative survival than in Finland, showed
fairly large and consistent survival differences between educational
and social groups (Shack et al, 2007; Dalton et al, 2008; Rachet
et al, 2008). Increased survival does not necessarily mean the
eradication of survival differences between subgroups (Coleman
et al, 2008). Studies in Finland have demonstrated systematic
differences by social class in cancer survival (Karjalainen and
Pukkala, 1990; Auvinen, 1992; Auvinen et al, 1995; Dickman et al,
1997). It is important to determine whether these differences
exist and their size, to plan actions on the basis of their likely
causes from which they might have emerged. The causes for
educational survival differences may be related to, e.g., behavioural
characteristics, tumour stage at diagnosis or the health care system
(Dalton et al, 2008).
The aim of the present study is to explore systematic social
differences in cancer survival in Finland and how it has changed
over time. Educational level was selected as the main variable
defining the social subgroups, as it has been shown to strongly
predict cancer survival in Denmark (Dalton et al, 2008) and as its
definition has remained comparable over time. The impact of these
differences was demonstrated by numbers and proportions of
potentially avoidable deaths under the assumption of cause-
specific survival in all educational groups being equal to that in the
subgroup with the highest education.
MATERIALS AND METHODS
Patients diagnosed with cancer in 1971–2005 and registered by the
countrywide Finnish Cancer Registry were linked, through the use
of the unique personal identity codes with the population censuses
done every 5 years in 1970–2000, to obtain information on
patients’ educational levels and occupations (Pukkala et al, 2009).
Persons born in 1906–80 were included in the analyses.
Using the most recent antecedent information from census, the
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the highest attained educational degree or certificate as follows:
basic (lasting typically o10 years), secondary (10–12 years) and
high education (13 years or more). Patients below 25 years of age
were excluded as their educational level was not necessarily the
final one.
Occupational details were used to create a supplementary group
that should be particularly conscious of their health and cancer
care possibilities, namely persons in medical and nursing work,
teaching work, research and physical education. In comparative
analyses involving in this category, such individuals were excluded
from the educational categories (mainly from the high educational
category) to form a fourth group. Cancers were divided into 27 site
categories (Table 1). The patients were followed up from diagnosis
until death, emigration or to the end of 2005, whichever came
first: for a few (0.13%), the follow-up was terminated owing to
emigration.
The main outcome measure of the patients was the cancer
(cause)-specific 5-year survival, where deaths owing to causes
other than the cancer of the patients are counted as events
censoring the follow-up time. The Cancer Registry corrects, when
necessary, the official cause-of-death information, as it has more
information than the person signing the death certificate
(Hakulinen and Teppo, 1977). The Registry receives, on average,
five notifications per cancer case, and registration is regarded as
reliable both in diagnostic accuracy and completeness (Teppo
et al, 1994; Curado et al, 2007).
The relative survival ratio, another measure preferred by
population based cancer registries in estimating the cause-specific
survival without relying on the quality of death certificates, was
used for comparison (Ederer et al, 1961). Here, mortality owing to
competing causes of death other than the patient’s cancer is
estimated as an overall mortality from the general population life
tables by sex, age and calendar period. A linkage between a 20%
random sample of the individuals from the censuses of 1970–2000
with the register of deaths and emigrations made it possible to also
obtain general population mortality rates in the three educational
categories. Thus, differences in general mortality by educational
category were taken into account in relative survival analyses. For
comparison, relative survival analyses without accounting for
educational level were also conducted. The estimation of relative
survival was based on the method of Hakulinen (1982).
Traditional direct age-standardisation was used for survival
comparisons between the educational groups, as the groups
differed in age structures (Pokhrel and Hakulinen, 2008); age
structure of all patients diagnosed in 1971–2005 was used as
a standard for each site. The ages used in the standardisation were
25–44, 45–54, 55–64, 65–74 and 75 years and more. This method
maintained the interpretability of the standardised figures and the
comparability between calendar periods, genders and educational
categories within a cancer site but not between sites. Results
were calculated for patient diagnosed in the periods 1971–85,
1986–95 and 1996–2005.
To study and control simultaneously for all prognostic variables,
the regression model of Hakulinen and Tenkanen (1987) was
used for the cancer (cause)-specific and relative survival analyses.
For the former, the expected survival was defined to be uniformly
one. The models included five annual follow-up intervals, sex,
age (the same categories as in age-standardisation), calendar
period (the three periods mentioned) and educational level (three
categories). In some analyses, the tumour stage was also included
as a covariate. Localised tumours were always classified separately
Table 1 Age-standardised 5-year cancer-specific survival proportions for the cancer patients diagnosed in Finland in 1996–2005 by site, sex and
educational level (high, secondary, basic) and differences (in % units) between the high and basic categories, by site and period. Patients’ site-specific age
distributions in 1971–2005 have been used as site-specific standards (both genders combined)
Males Females
Site ICD-10 code High Sec Basic Diff High Sec Basic Diff Number (1971–2005)
Lip C00 98.5 98.3 97.0 1.5 96.4 99.2 97.9  1.5 4212
Oesophagus C15 19.9 NA 9.5 10.4 NA NA NA NA 5687
Stomach C16 28.8 25.2 24.0 4.7 29.2 30.0 29.9  0.7 26958
Colon C18 54.8 57.9 54.5 0.3 60.1 61.1 55.8 4.3 28759
Rectum C19–20 59.8 55.7 52.7 7.1 62.4 57.1 56.8 5.6 19448
Liver C22 NA NA NA NA NA NA 7.5 NA 6445
Gallbladder C23–24 NA 15.9 NA NA 9.4 8.8 NA NA 6693
Pancreas C25 NA NA NA NA NA 3.6 2.6 NA 19328
Nose C30–31 NA NA NA NA 62.8 64.2 57.9 4.8 960
Lung C33–34 10.6 9.5 9.2 1.3 18.8 13.5 12.3 6.5 66014
Skin, melanoma C43 82.7 78.2 77.4 5.3 91.9 88.6 84.5 7.4 14750
Skin, non-melanoma C44 98.0 94.6 95.8 2.1 97.6 98.8 95.5 2.1 15383
Soft tissue C48–49 67.4 NA 47.1 20.3 62.6 60.2 60.7 1.9 3468
Breast C50 — — — — 89.4 87.1 84.9 4.5 78292
Cervix uteri C53 — — — — 78.5 69.0 63.3 15.1 5563
Corpus uteri C54 — — — — 87.8 83.7 82.2 5.6 17270
Ovary C56 — — — — 53.2 47.0 44.5 8.6 12948
Prostate C61 87.4 84.1 80.3 7.0 — — — — 59308
Testis C62 93.4 95.8 91.4 2.0 — — — — 1727
Kidney C64–65 61.1 58.9 55.2 5.9 62.1 63.6 60.8 1.3 18117
Urinary bladder C67–68 80.7 78.2 76.8 3.9 83.3 77.8 69.7 13.5 18037
Thyroid C73 84.2 85.9 82.6 1.5 93.9 92.6 91.1 2.8 8066
Hodgkin’s lymphoma C81 86.8 NA 83.4 3.3 86.2 86.3 82.5 3.7 3099
Non-Hodgkin’s lymphoma C82–85, C96 59.8 52.4 51.1 8.7 65.8 59.4 56.6 9.2 18818
Multiple myeloma C90 40.5 36.3 25.4 15.1 37.4 29.5 29.3 8.1 7023
Leukaemia C91–95 49.3 47.9 40.1 9.1 45.2 38.8 39.1 6.0 11865
Other cancers 39.2 40.0 33.3 5.8 44.5 39.6 34.7 9.8 47905
Total 526143
Abbreviation: NA¼not estimable; sec¼secondary; ICD¼international classification of diseases; Diff¼differences. Total numbers of cancer patients in 1971–2005 by site are
also given.
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metastases; distant metastases; non-localised, extent unknown;
unknown) depending on the site; the unknown stage category
comprised of 10–20% of tumours.
Interactions between age and follow-up year, and age and
stage were applied in all models including age and stage to allow
for non-proportional cause-specific or excess hazards by these
variables (Dickman et al, 2004). Cause-specific survival model
results are reported as relative risks (RRs) of cause-specific death
for a given category compared with a chosen reference category.
The corresponding quantities for relative survival models, the
relative risks of (cancer-related) excess mortality or the relative
excess risk (RER) of death were also derived.
Numbers and proportions of potentially avoidable deaths were
calculated for each educational group by assuming that the age-
and sex-specific hazards of dying were equal to those in the high
educational category by cancer site and cause of death (cancer of
the patients, other causes of death). First, the assumption was
made for cancer-specific mortality only. Second, the mortality
owing to the competing risks of death was, in addition, assumed to
be on the level observed in the high educational category. The
numbers of avoidable deaths for all sites combined were obtained
by summing the site-specific numbers. The theory of competing
risks of death (Chiang, 1968) was used to obtain the disease-
specific (‘crude’) probabilities of death needed in a hypothetical
situation of reduced cause-specific mortality.
RESULTS
The educational level could be identified from the censuses for
99.2% of patients; those with unknown education were excluded.
Altogether, 526143 patients were included in the analyses (Table 1).
Patients with basic education tended to be older than those with
a high education, and the educational level increased in the
population by calendar time.
The group with a high educational level had a higher age-
standardised cancer-specific 5-year survival than that with basic
educational level, almost without exception (Table 1). The
age-specific and, thereby, also the age-standardised 5-year
cancer-specific survival proportions and their differences could
not be estimated for every educational group in 1996–2005 for five
sites in males and four sites in females. Statistical modelling
showed that the higher survival among the highly educated had
persisted over calendar time. Differences in RRs of cancer-specific
mortality between the educational categories were larger when the
stage was not included in the model, and existed only when that RR
was under 0.85 (Figure 1). In other words, when there was a larger
mortality difference related to educational level, it was partly
accounted for by differences in stage distribution, almost regardless
of the site. The attenuation of the relative differences varied strongly
but was, with the exception of testicular and kidney cancers, quite
modest. The health-conscious occupational group still clearly had a
more favourable cancer-specific survival than the rest of the high
education category (Figure 2). The RRs of this group were also
somewhat attenuated when the stage was adjusted for by the model
compared with the results derived without adjusting for the stage.
The relative survival analysis, where the baseline general
mortality had been calculated specific to the educational category,
mostly gave similar results (RER) to those (RR) of the cause-
specific analyses (results not shown). Not using comparable
baseline mortality with respect to educational category resulted
in larger differences between the RERs and the RRs, which also
held true when stage was taken into account in the model.
If in the most recent period 1996–2005, the cancer-specific
mortality of all male and female patients equalled that of the high
education group, 8% of cancer deaths in patients diagnosed at ages
25–64 years during the first 5 years after diagnosis are
theoretically avoidable (Table 2). For ages 65–89, the correspond-
ing proportion is higher, 10%; these proportions are lower, 7%,
when prostate and breast cancers are excluded. When the same
estimation is done for the first 10 years after diagnosis, the
numbers and proportions of avoidable cancer deaths decrease. At
25–64 years, the proportions of avoidable deaths were fairly stable
over time. In contrast, in the first 5-year follow-up period after
diagnosis, there has been a clear increase in them at ages 65–89
years, even when prostate and breast cancers are excluded. There
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Figure 1 Risk ratios for cancer death of patients diagnosed in 1971–2005 (high vs basic education) without and with accounting for stage, by site (sites:
OE¼oesophagus; ST¼stomach; CO¼colon; RE¼rectum; LI¼liver; GB¼gallbladder; PA¼pancreas; LU¼lung; ME¼skin, melanoma; NM¼skin,
non-melanoma; BR¼breast; CE¼cervix uteri; CU¼corpus uteri; OV¼ovary; PR¼prostate; KI¼kidney; UB¼urinary bladder; TH¼thyroid;
HL¼Hodgkin’s lymphoma; NHL¼non-Hodgkin’s lymphoma; OTH¼other cancers as specified in Table 1). The model accounts for gender where
applicable. The diagonal indicates equality of the two RRs. Results are shown for sites with model convergence only.
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Figure 2 Risk ratios for cancer death high vs basic education and health-conscious occupational group vs basic education and for patients diagnosed
in 1996–2005, by site (sites: ST¼stomach; CO¼colon; RE¼rectum; PA¼pancreas; LU¼lung; ME¼skin, melanoma; NM¼skin, non-melanoma;
BR¼breast; CE¼cervix uteri; CU¼corpus uteri; OV¼ovary; PR¼prostate; KI¼kidney; TH¼thyroid; NHL¼non-Hodgkin’s lymphoma; LE¼leukaemia;
OTH¼other cancers as specified in Table 1). The model accounts for gender where applicable. Persons in the health-conscious occupational group have
been removed from the education categories. The diagonal indicates equality of the two RRs.
Table 2 Number (N) and proportion (%) of potentially avoidable cancer deaths in Finland by period, age and site in a hypothetical situation where all
patients would have the same cancer-specific mortality as those with a high education
1971–1985 1986–1995 1996–2005
5-year 10-year 5-year 10-year 5-year 10-year
Age/site N % N % N % N % N % N %
25–64 years
Stomach 64 1 87 2  5 0 19 1  8  1  30  2
Colon and rectum 162 5 197 6 324 15 339 14 83 3 35 1
Lung 332 3 320 3 24 0 26 0 239 4 214 4
Skin, melanoma 189 27 228 26 61 12 118 19 143 31 224 36
Skin, non-melanoma 36 59 43 63 21 76 21 61 10 29 15 38
Breast 358 10 534 11 530 22 516 14 356 17 387 11
Female genital organs 537 20 512 17 208 13 241 13 197 13 216 11
Prostate 96 11 75 7 141 16 136 12 303 27 369 20
Urinary organs 390 20 428 19 183 13 220 14 37 3  58  4
Leukaemia 62 4 99 6 6 1 46 5 150 23 144 18
Non-Hodgkin’s lymphoma 102 8 39 3 107 10 115 8 195 18 104 7
Other sites 778 7 618 5 544 7 508 6 481 6 405 4
Total 3105 7 3180 7 2143 8 2305 8 2188 8 2026 7
Total excluding. prostate and breast 2652 7 2571 6 1472 6 1653 6 1528 7 1270 5
65–89 years
Stomach 121 3 48 1 131 3 112 2 192 5 186 5
Colon and rectum 168 6 243 8 495 9 463 8 504 8 395 6
Lung 69 1 66 1 201 2 192 2 180 1 109 1
Skin, melanoma 36 17 20 8 63 16 72 15 102 17 39 6
Skin, non-melanoma  3  4 3 5 46 33 60 37 93 43 102 45
Breast 224 18 253 15 550 28 718 27 616 26 408 12
Female genital organs 222 15 214 13 311 12 293 11 599 22 506 17
Prostate 137 8 39 2 541 15 617 13 1397 31 1764 25
Urinary organs 243 16 241 14 438 16 467 15 490 15 487 13
Leukaemia 27 3 67 6  24  2  20  1 23 1 97 5
Non-Hodgkin’s lymphoma 141 17 176 19 193 9 171 8 466 17 351 12
Other sites 290 3 357 4 785 5 744 5 1351 7 1293 6
Total 1675 5 1727 5 3730 7 3889 7 6014 10 5737 9
Total excluding prostate and breast 1314 5 1435 5 2638 6 2554 5 4001 7 3565 6
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follow-up period after diagnosis, which almost disappears after
excluding prostate and breast cancers. The numbers and propor-
tions of potentially avoidable deaths varied greatly by cancer site
(Table 2). Proportions exceeding 10% were obtained for cancers of
the skin, breast, female genital organs, prostate and urinary
organs, whereas practically no or few avoidable deaths were
obtained for stomach and lung cancers.
The avoidable cancer deaths will contribute to an increase in the
number of persons exposed to competing causes of death, so, there
will be negative numbers in the avoidable deaths owing to causes
other than the cancer (Table 3, upper panel A). At ages 25–64
years, the total proportion of avoidable deaths is 5–7% in the first
5 years and about 3–5% in the first 10-year period after diagnosis;
at ages 65–89 years, the respective proportions are 4–6 and 3%.
By assuming that both the cancer-specific mortality and the
mortality owing to other causes would be the same as those
observed in patients with high education, the numbers and
proportions of avoidable cancer deaths are slightly smaller than
those without the assumption of an improved mortality from
other causes of death (Table 3, lower panel B). On the other hand,
marked numbers of avoidable deaths from other causes are
obtained, ranging from 9 to 28%. At ages 25–64 years, avoidable
deaths, regardless of the cause, are 8–10% during the first 5 years
of follow-up after diagnosis and 7–8% in the first 10 years; at ages
65–89 years, these proportions are 8–11 and 6–8%, respectively.
DISCUSSION
It has been previously shown and generally accepted that cancer
incidence is strongly influenced by a person’s social position or
education, as the risk factors of cancer have not evenly distributed
(Pukkala, 1995; Dalton et al, 2008). It is less easy to accept that
cancer survival should depend on these factors as this may indicate
differential access to care. Nordic countries, among them Finland,
have been emphasising equality among residents as far as health
care services are concerned. Cancer control plans have been made
in Finland since 1952 to secure equal rights and potential access to
services (Finnish Cancer Committee, 1984). Our study suggests
that this goal has not been reached.
Social group differences in cancer survival have been seen wherever
it has been studied (Kogevinas et al, 1997; Mackillop et al, 1997;
Rosso et al, 1997; Singh et al, 2003; Madison et al, 2004; Dejardin
et al, 2006; Shack et al, 2007; Dalton et al, 2008; Rachet et al, 2008).
Several factors related to risk profiles, tumour characteristics or
the health system might lie behind these survival differences.
Risk-factor related risks of death may well be working to
different extents for patient survival in different groups (Dalton
et al, 2008). It is quite conceivable that cancer survival, not only
survival with respect to competing causes of death, will depend on
factors like smoking, alcohol use and nutritional status, which may
also influence the available treatment options.
In a country with good equity in health services, it may sound
implausible that health services are better targeted towards the
more educated, but the less educated may well be less aware of
early symptoms and may experience a delay in diagnosis (Auvinen
et al, 1995; Neal and Allgar, 2005; Hansen et al, 2008). Indeed,
when the stage distribution was adjusted for, the cancer-specific
survival figures of the educational groups were closer.
Early detection by the prostate-specific antigen (PSA) test will
increase the apparent survival for prostate cancer (Schro ¨der et al,
2009), and higher educated persons may have more intense PSA
diagnostics than others. There is also an increase in survival
for breast cancer patients related to mammographic screening
(Berry et al, 2005), and that may be associated with the education
of patient due to differences in the proportion of participation. A
higher education may help in navigating within the health system
thus enabling better and more timely care. For example, a higher
education of the patient can improve the patient–doctor interac-
tion and the ability to follow care regimens. The fact that the
health-conscious patient group (e.g., doctors, nurses, teachers)
clearly had the highest cancer-specific survival figures points out
that much is achievable, provided that their cancer outcomes could
be achieved for everyone. Although higher educated patients may
have better financial resources to obtain additional care from the
private sector, in Finland this did not exist during the period
studied.
The numbers and proportions of avoidable deaths have been
used as a measure of what possibly could be achieved if cancer
patients’ relative survival could be raised to an optimal level
defined by a higher survival in other subgroups (Dickman et al,
1997) or other populations (Abdel-Rahman et al, 2009). These
quantities should be estimated regardless of the cause, as some of
the persons saved from cancer death are likely to die from
competing causes of death even within a 5- or 10-year period after
Table 3 Number (N) and proportion (%) of potentially avoidable deaths due to cancer and other causes in cancer patients in Finland in 1996–2005, by
age, in two hypothetical situations: (A) all patients would have the same cancer-specific mortality and (B) same cancer and competing-risk mortality as those
with a high education
Cancer Other Total
5-year 10-year 5-year 10-year 5-year 10-year
Age at cancer diagnosis N % N % N % N % N % N %
A. Same cancer-specific mortality
25–64 years
Total 2188 8 2026 7  167  5  330  5 2021 7 1696 5
Total excluding prostate and breast 1528 7 1270 5  148  6  266  6 1380 5 1004 3
65–89 years
Total 6014 10 5737 9  1371  6  2480  7 4642 6 3257 3
Total excluding prostate and breast 4001 7 3565 6  1062  7  1575  7 2939 4 1990 3
B. Same cancer-specific and competing-risk mortality
25–64 years
Total 1984 8 1703 6 963 27 1365 22 2947 10 3068 8
Total excluding prostate and breast 1339 6 986 4 713 28 957 23 2052 8 1943 7
65–89 years
Total 5035 8 4093 6 4054 17 3867 10 9089 11 7960 8
Total excluding prostate and breast 3191 6 2478 4 2186 15 2054 9 5377 8 4532 6
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mortality will wear them off rapidly, depending on the age of the
patients. Rather than ‘avoidable’ the term could be ‘postponable’
deaths, and person-years saved (Hakulinen and Teppo, 1976) or
expected life years lost per patient might be more useful (Hakama
and Hakulinen, 1977; Seppa ¨ and Hakulinen, 2009).
CONCLUSION
Clear educational differences in cancer patient survival are
still observed in Finland, despite the level of survival being
internationally very high and regardless of the very strong
improvement in survival over the past decades.
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